Breast Reconstruction Market: Current Analysis and Forecast (2022-2028)

Breast Reconstruction Market: Current Analysis and Forecast (2022-2028)

The breast reconstruction market is expected to register a CAGR of around ~5.1% over the period of 2022-2028. This is mainly due to its increasing number of breast cancer patients, availability, and advancements in surgical techniques, the urge to ameliorate breast size & shape, especially among women, and raising awareness and concerns about breast cancer. Also, breast reconstruction has stringent government regulations coupled with the growing focus of major stakeholders in the healthcare industry to adopt to make products more sustainable with fewer side effects and cost-effective. Moreover, an increase in the number of breast reconstruction procedures, along with technological advancements is expected to impel market growth. For instance, according to the WHO, around 2.3 million women globally were diagnosed with breast cancer in the year 2020. Thus, as a result of the increase in the number of people suffering from breast cancer, the demand for breast reconstruction is expected to increase. Furthermore, various factors such as growing research and development activities are also expected to drive the demand for breast reconstruction over the forecast period which is responsible for the excessive use and also significantly contributes to the market for the medical applications of breast reconstruction. Therefore, the market for breast reconstruction is expected to witness significant growth during the forecast period.

• Based on product type, the market is categorized into breast implants, tissue expanders, acellular dermal matrices, and others. Among these, breast implants are expected to witness the highest CAGR during the forecast period. This is mainly due to the rising use of breast implants during breast augmentation surgeries are widely used technology and have many benefits such as the compact size of devices and minimum power requirements. For instance, according to the NCBI, around 8.08 women per 1,000 in the U.S. has one or other kind of breast implant.
• Based on procedure, the market is classified into immediate, delayed, and revision. Amongst these, the alcohol detection category accounted for a significant share of the market. This is mainly due to its immediate reconstruction method being a better option due to its aesthetic effect, cost-effectiveness, and psychological effects and most women opt for the immediate reconstruction method. For instance, in May 2021, GC Aesthetics launched its next-generation round silicone breast implant PERLE. Over the forthcoming years, this segment rising due to the use of breast reconstruction in the global market is likely to boost the demand for breast reconstruction.
• Based on placement, the market is classified into dual-plane insertion, subglandular insertion, and submuscular insertion. Amongst these, the dual-plane insertion category accounted for a significant share of the market. This is mainly because that method supports breast inserts to be placed in the most accurate position and guarantees enough coverage of the soft tissue. Over the forthcoming years, this segment rising due to the use of breast reconstruction in the global market is likely to boost the demand for breast reconstruction.
• Based on end user, the market is categorized into hospitals, ambulatory surgical centers, cosmetology clinics, and others. Among these, hospitals are expected to witness the highest CAGR during the forecast period. The dominance of the segment can be attributed to a rise in the number of hospitals worldwide. For instance, according to the Athar Institute of Health Management & Studies, the hospitals in India makeup 80% of the total healthcare market.
• For a better understanding of the market adoption of the breast reconstruction industry, the market is analyzed based on its worldwide presence in the countries such as North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Spain, and Rest of Europe); Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific), and Rest of World. North America is expected to witness the highest CAGR during the forecast period. This can be attributed due to the rising number of breast cancer patients coupled with high product adoption rates, and awareness about breast reconstruction in the U.S. economy in this region. For instance, as per the Canadian Cancer Society, approximately 78 Canadian women are diagnosed with breast cancer every day, whereas, 15 women die of breast cancer every day. Moreover, around 28,600 Canadian women are predicted to be diagnosed with breast cancer in the year 2022. Thus, the growing consumption of alcohol, increasing research on the medical applications of breast reconstruction, and the development of advanced breast reconstruction by major companies and the diagnostics industry owing to the presence of well-established market players and frequent product launches in the region.
• Some of the major players operating in the market include Mentor Worldwide LLC, Allergan Inc., Johnson & Johnson, SientraInc., GC Aesthetics, Ideal Implant Incorporated, POLYTECH Health & Aesthetics GmbH, CEREPLAS, AbbVie Inc., Establishment Labs S.A.